DRUGS IN THE TREATMENT OF TELOGEN HAIR LOSS
- Authors: Korsunskaya I.M.1,2, Melnichenko O.O.1,2
-
Affiliations:
- Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences
- Moscow Research and Practical Center for Dermatovenereology and Cosmetology, Moscow Healthcare Department
- Issue: Vol 68, No 5 (2019)
- Pages: 18-21
- Section: Articles
- URL: https://journals.eco-vector.com/0367-3014/article/view/113132
- DOI: https://doi.org/10.29296/25419218-2019-05-03
- ID: 113132
Cite item
Open Access
Access granted
Abstract
Telogen hair loss is a common type of alopecia. It is characterized by a sudden onset and can occur in both women and men at any age. Factors that can provoke both acute and chronic telogen hair loss, as well as drugs used in its therapy are considered. Exogenous (drugs and various chemicals) and endogenous (infectious diseases) intoxications play a substantial role in the development of this disease. Drug therapy for telogen hair shedding is based on the correction of nutrient, vitamin, and mineral deficiencies. The vitamin and mineral complexes prescribed should contain protein, essential fatty acids, zinc, selenium, copper, vitamin C, biotin, vitamins B, L-cysteine, if necessary, iron, copper, and folic acid. The patients with telogen hair loss may have a favorable prognosis when the causal factors are eliminated.
Keywords
Full Text
About the authors
Irina Markovna Korsunskaya
Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences; Moscow Research and Practical Center for Dermatovenereology and Cosmetology, Moscow Healthcare Department
Email: marykor@bk.ru
Professor, MD; Head, Laboratory of Physicochemical and Genetic Bases of Dermatology, Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences Moscow, Russian Federation
Olga Olegovna Melnichenko
Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences; Moscow Research and Practical Center for Dermatovenereology and Cosmetology, Moscow Healthcare Department
Email: dr.melnichenko@gmail.com
Dermatovenereologist, Moscow Research and Practical Center for Dermatovenerology and Cosmetology, Healthcare Department, Candidate of Medical Sciences Moscow, Russian Federation
References
- Werner B., Mulinari-Brenner F. Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata. Part II. An. Bras. Dermatol., 2012 Nov-Dec; 87 (6): 884-890.
- Bing Zhang, Ya-Chieh Hsu. Emerging roles of transit-amplifying cells in tissue regeneration and cancer. Wiley Interdiscip. Rev. Dev. Biol., 2017 Sep; 6 (5): 10.
- Gilmore S., Sinclair R. Chronic telogen effluvium is due to a reduction in the variance of anagen duration. Australas J. Dermatol., 2010; 51 (3): 163-167.
- Mulinari-Brenner F., Bergfeld W. Entendendo o Efluvio Telogeno. An. Bras. Dermatol., 2002; 77: 87-94.
- Rushton D.H. Nutritional factors and hair loss. Clin. Exp. Dermatol., 2002; 27(5): 396-404.
- Ong K.H., Tan H.L., Lai H.C., Kuperan P. Accuracy of various iron parameters in the prediction of iron deficiency in an acute care hospital. Ann. Acad. Med. Singapore., 2005 Aug; 34(7): 437-440.
- Sinclair R. There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br. J. Dermatol., 2002 Nov; 147(5): 982-984.
- Sobolev V., Sakaniya L., TretiakovA.et al. Association of GA genotype of SNP rs4680 in COMT gene with psoriasis. Arch. Dermatol. Res. 2019; 311 (4): 309-315.
- Klimov E., Tretiakov A., Gapanovich E. et al. Assessment of the Role of NO Synthase Genes Polymorphisms in the Pathogenesis of Psoriasis. Journal of Advances in Medicine and Medical Research. 2018; 26 (4): 1-6. Article no.JAMMR.41039. https://doi.org/10.9734/JAMMR/2018/41039.
- Соболев В.В., Третьяков А.В., Шевцова А.А. и др. Связь между однонуклеотидной заменой T>C в гене MIR22 и развитием псориаза. Эффективная фармакотерапия,2018; 34: 18-20.
- Климов Е.А., Малахова А.В., Коробейникова Л.А. и др. Ассоциации полиморфных вариантов генов холецистокининергической системы с паническим расстройством. Медицинский совет, 2018; 12: 190-194. doi: 10.21518/2079-701X-2018-12
- Денисова Е.В., Дворянкова Е.В., Плиева К.Т.и др. Патологии гепатобилиарной системы у больных псориазом. Эффективная фармакотерапия, 2018; 21: 18-23.
- Дерматовенерология. Национальное руководство. (под ред. Ю.С. Бутова, Ю.К. Скрипкина, О.Л. Иванова.). М.: ГЭОТАР-Медиа, 2013; 896.
- Ральф М. Трюб. Сложный пациент трихолога. Руководство по эффективному лечению алопеций и сопутствующих заболеваний. М.: ГЭОТАР-Медиа, 2018; 392.
- Гаджигороева А.Г. Клиническая трихология. M.: Практическая медицина, 2014; 184.
Supplementary files
